Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 292: C8-C23, 2007. First published June 28, 2006; doi:10.1152/ajpcell.00232.2006
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/C8    most recent
00232.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parihar, M. S
Right arrow Articles by Brewer, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parihar, M. S
Right arrow Articles by Brewer, G. J.

INVITED REVIEWS

Mitoenergetic failure in Alzheimer disease

Mordhwaj S Parihar1 and Gregory J. Brewer1,2

1Department of Medical Microbiology, Immunology and Cell Biology; and 2Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois

Brain cells are highly energy dependent for maintaining ion homeostasis during high metabolic activity. During active periods, full mitochondrial function is essential to generate ATP from electrons that originate with the oxidation of NADH. Decreasing brain metabolism is a significant cause of cognitive abnormalities of Alzheimer disease (AD), but it remains uncertain whether this is the cause of further pathology or whether synaptic loss results in a lower energy demand. Synapses are the first to show pathological symptoms in AD before the onset of clinical symptoms. Because synaptic function has high energy demands, interruption in mitochondrial energy supply could be the major factor in synaptic failure in AD. A newly discovered age-related decline in neuronal NADH and redox ratio may jeopardize this function. Mitochondrial dehydrogenases and several mutations affecting energy transfer are frequently altered in aging and AD. Thus, with the accumulation of genetic defects in mitochondria at the level of energy transfer, the issue of neuronal susceptibility to damage as a function of age and age-related disease becomes important. In an aging rat neuron model, mitochondria are both chronically depolarized and produce more reactive oxygen species with age. These concepts suggest that multiple treatment targets may be needed to reverse this multifactorial disease. This review summarizes new insights based on the interaction of mitoenergetic failure, glutamate excitotoxicity, and amyloid toxicity in the exacerbation of AD.

bioenergetics; synaptic dysfunction; neurodegeneration; nicotinamide adenine dinucleotide; free radicals; mitochondrial membrane potential



Address for reprint requests and other correspondence: G. J. Brewer, Dept. of Medical Microbiology, Immunology and Cell Biology and Dept. Neurology, Southern Illinois Univ. School of Medicine, Springfield, IL 62794-9626 (e-mail: gbrewer{at}siumed.edu)




This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. Nilsen, R. W. Irwin, T. K. Gallaher, and R. D. Brinton
Estradiol In Vivo Regulation of Brain Mitochondrial Proteome
J. Neurosci., December 19, 2007; 27(51): 14069 - 14077.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.